Yuji Ishibashi

Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression

Yuji Ishibashi, Takanori Matsui, Masayoshi Takeuchi et al. · Biochemical and Biophysical Research Communications · 2009 · 172 citations

Life Sciences, Endocrinology, Physiology +14

Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor

Yuji Ishibashi, Takanori Matsui, Sayaka Maeda et al. · Cardiovascular Diabetology · 2013 · 165 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

Ayako Ojima, Yuji Ishibashi, Takanori Matsui et al. · American Journal Of Pathology · 2012 · 154 citations · Full text

Medicine, Endocrinology, Pharmacology +12

Interaction cross sections for Ne isotopes towards the island of inversion and halo structures of 29Ne and 31Ne

M. Takechi, T. Ohtsubo, Mitsunori Fukuda et al. · Physics Letters B · 2011 · 142 citations

Natural Sciences, Earth Sciences, Nuclear Chemistry +5

Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation

Yuji Ishibashi, Takanori Matsui, Sho‐ichi Yamagishi · Hormone and Metabolic Research · 2015 · 116 citations

Medicine, Nephrology, Pharmacology +17